Smi
Country not established
- Devices
- 1
What Smi makes
Smi manufactures the SpectroPad System, a handheld device designed for spectral analysis and measurement in clinical or laboratory settings, likely for applications such as blood glucose monitoring or other biochemical assessments.
The SpectroPad System is classified as a Class II medical device in the US and is listed under the FDA’s 510(k) pathway. The company is based in the United States.
Catalogue
Spectropad System Ref K931261
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Smi have in the registry?
The registry currently lists 1 device for Smi. Devices recorded under merged duplicate company entries are counted once.
Which registries list Smi's devices?
Among its 1 most recently registered device, Smi has devices listed in FDA 510(k) (1 device).
What risk classes do Smi's devices fall under?
Among its 1 most recently registered device, the classes recorded for Smi's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Smi in the registry?
The most recently registered devices listed for Smi include SPECTROPAD SYSTEM.